(주)에스엔이바이오

{
  "address": "서울특별시 강남구",
  "ceo_name": "방오영",
  "certificate": [
    {
      "cert_number": "20200300368",
      "changes": "",
      "disclosure_date": "2020-04-09",
      "first_cert_date": "2020-04-09",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2020-04-09 ~ 2022-04-08"
    },
    {
      "cert_number": "20220302010076",
      "changes": "",
      "disclosure_date": "2022-03-02",
      "first_cert_date": "2020-04-09",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-04-09 ~ 2025-04-08"
    },
    {
      "cert_number": "20250311010026",
      "changes": "",
      "disclosure_date": "2025-03-11",
      "first_cert_date": "2020-04-09",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-04-09 ~ 2028-04-08"
    }
  ],
  "company_name": "(주)에스엔이바이오",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 524063000,
      "cost_of_sales": 0,
      "current_assets": 6682188000,
      "current_liabilities": 41632000,
      "gross_profit": 80000000,
      "net_income": -2368378000,
      "net_income_bs": -2368378000,
      "non_current_assets": 916953000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 1036101000,
      "operating_profit": -3404479000,
      "revenue": 80000000,
      "sga_expenses": 3484479000,
      "total_assets": 7599141000,
      "total_equity": 7557509000,
      "total_liabilities": 41632000
    },
    "2023": {
      "capital_stock": 552088000,
      "cost_of_sales": 0,
      "current_assets": 4844915000,
      "current_liabilities": 130961000,
      "gross_profit": 0,
      "net_income": -4059408000,
      "net_income_bs": -4059408000,
      "non_current_assets": 819751000,
      "non_current_liabilities": 236626000,
      "non_operating_expenses": 0,
      "non_operating_income": 106534000,
      "operating_profit": -4165942000,
      "revenue": 0,
      "sga_expenses": 4165942000,
      "total_assets": 5664666000,
      "total_equity": 5297079000,
      "total_liabilities": 367587000
    },
    "2024": {
      "capital_stock": 552089000,
      "cost_of_sales": 579000,
      "current_assets": 3617465000,
      "current_liabilities": 2168649000,
      "gross_profit": 930000,
      "net_income": -3320003000,
      "net_income_bs": -3320003000,
      "non_current_assets": 804931000,
      "non_current_liabilities": 276671000,
      "non_operating_expenses": 60348000,
      "non_operating_income": 59954000,
      "operating_profit": -3319609000,
      "revenue": 1509000,
      "sga_expenses": 3320539000,
      "total_assets": 4422396000,
      "total_equity": 1977076000,
      "total_liabilities": 2445320000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,999,994,880",
      "changes": "1,999,994,880",
      "date": "2023-03-29"
    },
    {
      "amount": "1,999,999,000",
      "changes": "1,999,999,000",
      "date": "2020-02-19"
    },
    {
      "amount": "999,000,000",
      "changes": "999,000,000",
      "date": "2020-02-19"
    },
    {
      "amount": "999,000,000",
      "changes": "999,000,000",
      "date": "2020-02-14"
    }
  ],
  "main_products": "무세포치료제",
  "phone": "02-2054-****",
  "years": [
    2024,
    2023,
    2022
  ]
}